Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the detailed record of transactions filed by YOUNG WILLIAM D, Director. Director active across 2 companies, notably Praxis Precision Medicines, Inc.. Aggregated, 3 filings have been recorded. History available since 13 May 2021. The latest transaction was filed on 26 April 2022 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
3 of 3 declarations
Young William D is a Director at Praxis Precision Medicines, Inc. and Theravance Biopharma, Inc. In this role, he oversees the activities of these companies and participates in strategic decision-making. William is committed to promoting transparency and ensuring that shareholder interests are considered in all decisions.